PVP Ventures announces 35th AGM on Sep 7, 2026; details book closure and e-voting dates
PVP Ventures Limited will hold its 35th AGM on September 7, 2026, via VC/OAVM. Key events include adopting FY26 financial statements, appointing new auditors for five years, and approving a name change to 'Evervie Health Limited'. The company will also appoint new directors and senior management, including a CEO and COO, and approve an ESOP scheme.
The announcement details several significant corporate actions including a name change, appointment of key management personnel, and approval of an employee stock option scheme, which can have a medium-term impact on the company's structure and governance.
The announcement is a routine notice for an Annual General Meeting and related corporate actions. While it involves significant agenda items like director appointments and name change, it does not contain new financial performance data or strategic shifts that would strongly influence sentiment.
PVP Ventures Limited has announced its 35th Annual General Meeting (AGM) will be held on Monday, September 7, 2026, at 10:00 AM IST via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has also specified the relevant dates for voting and book closure.
The cut-off/record date to vote on AGM resolutions is August 31, 2026. The book closure period will be from September 1, 2026, to September 7, 2026, inclusive. E-voting will commence on September 4, 2026, at 9:00 AM IST and conclude on September 6, 2026, at 5:00 PM IST.
During the AGM, the company will transact ordinary business including the adoption of audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and the appointment of M/s. CNGSN & ASSOCIATES LLP as statutory auditors for a term of five years. Special business includes approval of material related party transactions with several entities, a change of name from PVP Ventures Limited to 'Evervie Health Limited', the appointment of Ms. Saloni Khandelwal and Mr. Srivatsan Kalyanasundaram as Non-Executive Independent Directors, and Dr. Ellen Feehan as Executive Director and CEO, and Dr. Neeraja Nagarajan as Executive Director and COO. The AGM will also seek approval for the payment of managerial remuneration to Mr. Prasad V. Potluri, Chairman and Managing Director, and fees for collateral securities and personal guarantees provided by him. Additionally, shareholders will vote on the approval of the PVP Ventures Employee Stock Option Scheme 2026 (PVP ESOP 2026), extending the scheme to eligible employees of associate and subsidiary companies, and the grant of stock options exceeding 1% of the issued capital to an identified employee.
The company has also provided notes regarding the conduct of the AGM through VC/OAVM in compliance with MCA and SEBI circulars, the dispensing of physical attendance, and the non-availability of proxy forms. Information regarding corporate/institutional members' representatives, joining the AGM, joint holders, and the electronic mode of sending the Annual Report for FY 2025-26 has also been detailed.
What to do with a filing like this
PVP Ventures Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by PVP Ventures Limited. Read the original for the full detail.